Sep 1, 2026 04:23AM
Aug 4, 2026 06:00AM
Jun 1, 2026 11:00AM
Jun 1, 2026 11:00AM
May 14, 2026 09:15AM
May 5, 2026 06:00AM
Apr 30, 2026 06:01AM IDEAYA begins FDA application for uveal melanoma drug under fast-track program
Apr 30, 2026 06:00AM
Apr 13, 2026 01:29PM
Apr 13, 2026 06:00AM
Apr 13, 2026 06:00AM
Mar 23, 2026 04:56AM
Feb 17, 2026 06:00AM
Feb 6, 2026 04:45AM Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens: Shares Can Gain
Jan 11, 2026 12:00PM
Dec 11, 2025 06:00AM
Dec 11, 2025 06:00AM
Dec 10, 2025 06:01AM
Dec 10, 2025 06:00AM
Dec 4, 2025 07:00PM
Dec 1, 2025 06:00AM IDEAYA Biosciences receives FDA clearance for cancer drug trial
Dec 1, 2025 06:00AM
Nov 4, 2025 06:00AM
Oct 20, 2025 06:30AM
Oct 20, 2025 06:30AM
Oct 7, 2025 07:53AM
Sep 11, 2025 08:18AM
Sep 8, 2025 08:00AM IDEAYA reports phase 1/2 trial data for cancer drug combination
Sep 8, 2025 08:00AM
Sep 3, 2025 06:00AM
Sep 3, 2025 06:00AM
Sep 2, 2025 06:01AM
Sep 2, 2025 06:00AM
Aug 5, 2025 06:00AM
Jul 24, 2025 09:25AM IDEAYA to present darovasertib trial data at ESMO 2025 conference
Jul 24, 2025 09:25AM
May 6, 2025 06:05AM
May 6, 2025 06:01AM
May 6, 2025 06:00AM
Apr 14, 2025 06:00AM
Apr 14, 2025 06:00AM
Mar 31, 2025 06:29AM IDEAYA Biosciences (IDYA) Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma
Mar 31, 2025 06:00AM
Feb 13, 2025 06:05AM
Jan 2, 2025 04:00PM
Dec 21, 2024 10:00AM
Dec 17, 2024 06:00AM
Dec 16, 2024 06:04AM
Dec 16, 2024 06:00AM IDEAYA Announces Development Candidate Nomination of IDE251, a Potential First-in-Class KAT6/7 Dual Inhibitor Targeting 8p11 Amplification Tumors in Breast and Lung Cancers
Dec 10, 2024 06:01AM

329,957 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All